Layilin Inhibitors
Layilin inhibitors belong to a distinctive chemical class characterized by their ability to modulate the interaction between layilin and its binding partners. Layilin, a transmembrane protein found on the cell surface, plays a role in mediating cell adhesion, migration, and signal transduction. The inhibitors designed for layilin are engineered compounds that possess the capacity to disrupt the interaction between layilin and its specific ligands. These inhibitors typically act by competitively binding to either the extracellular domain of layilin or to its binding partners, thereby preventing the formation of stable complexes and interfering with downstream cellular processes.
The development of layilin inhibitors is an area of ongoing research, aimed at elucidating the precise mechanisms of cell adhesion and migration, and revealing new insights into the regulation of cellular behaviors. The unique characteristics of layilin inhibitors make them intriguing tools for investigating cell biology and understanding the intricacies of cell-surface interactions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $209.00 $352.00 | 3 | |
LY2157299 is a TGF-β receptor type I kinase inhibitor. It blocks the signaling of the TGF-β pathway, which is involved in various cellular processes, including cell growth, differentiation, and immune response. | ||||||
TGF-β RI Kinase Inhibitor VIII | 356559-20-1 | sc-203295 | 2 mg | $100.00 | 2 | |
SB525334 is another TGF-β receptor type I kinase inhibitor. It prevents the activation of the TGF-β pathway, which plays a role in tissue fibrosis and cancer progression. | ||||||
3-Aminopropionitrile | 151-18-8 | sc-266473 | 1 g | $102.00 | ||
β-Aminopropionitrile (BAPN) is a lysyl oxidase (LOX) inhibitor. It interferes with collagen cross-linking by inhibiting LOX activity, which is essential for stabilizing the extracellular matrix. | ||||||
JIB 04 | 199596-05-9 | sc-397040 | 20 mg | $177.00 | ||
JIB-04 is also an inhibitor of lysine-specific demethylase 1A (LSD1). It modulates epigenetic mechanisms by inhibiting LSD1, potentially influencing gene expression patterns related to various diseases. | ||||||
2,3-Dihydroxy-6-methyl-7-(phenylmethyl)-4-propyl-1-naphthalenecarboxylic Acid | 213971-34-7 | sc-498807 | 1 mg | $480.00 | ||
FX-11 is a pyruvate dehydrogenase kinase (PDK) inhibitor. By blocking PDK, it promotes the activity of pyruvate dehydrogenase (PDH), leading to enhanced glucose metabolism, which could influence cellular processes and diseases. | ||||||